Article
Variations in predicted risks in personal genome testing for common complex diseases.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2014
Kalf Rachel R J, Mihaescu Raluca, Kundu Suman, de Knijff Peter, Green Robert C, Janssens A Cecile J W
Abstract excerpt
PURPOSE: The promise of personalized genomics for common complex diseases depends, in part, on the ability to predict genetic risks on the basis of single nucleotide polymorphisms. We examined and compared the methods of three companies (23andMe, deCODEme, and Navigenics) that have offered direct...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
